REFERENCES
1. Becker K, Sander P. Mycobacterium tuberculosis lipoproteins in virulence and immunity - fighting with a double-edged sword. FEBS Lett 2016;590:3800-19.
2. Scuotto A, Djorie S, Colavizza M, Romond PC, Romond MB. Bifidobacterium breve C50 secretes lipoprotein with CHAP domain recognized in aggregated form by TLR2. Biochimie 2014;107 Pt B:367-75.
3. Scuotto A, Romond P, Djorie S, Alric M, Romond MB. In silico mining and characterization of bifidobacterial lipoprotein with CHAP domain secreted in an aggregated form. Int J Biol Macromol. 2016;82:653-62.
4. Hoarau C, Lagaraine C, Martin L, Velge-Roussel F, Lebranchu Y. Supernatant of Bifidobacterium breve induces dendritic cell maturation, activation, and survival through a Toll-like receptor 2 pathway. J Allergy Clin Immunol 2006;117:696-702.
5. El Kfoury KA, Romond MB, Scuotto A, et al. Bifidobacteria-derived lipoproteins inhibit infection with coxsackievirus B4 in vitro. Int J Antimicrob Agents 2017;50:177-85.
6. Romond MB, Ais A, Yazourh A, Romond C. Cell-free wheys from bifidobacteria fermented milks exert a regulatory effect on the intestinal microflora of mice and humans. Anaerobe 1997;3:137-43.
7. Romond MB, Ais A, Guillemot F, Bounouader R, Cortot A, Romond C. Cell-free whey from milk fermented with Bifidobacterium breve C50 used to modify the colonic microflora of healthy subjects. J Dairy Sci 1998;81:1229-35.
8. Mullié C, Yazourh A, Singer E, et al. Partial characterization of bifidobacterium breve C50 cell-free whey compounds inducing modifications to the intestinal microflora. J Dairy Sci 2002;85:1383-9.
9. Martel-Pelletier J, Barr AJ, Cicuttini FM, et al. Osteoarthritis. Nat Rev Dis Primers 2016;2:16072.
10. Collins KH, Reimer RA, Seerattan RA, Leonard TR, Herzog W. Using diet-induced obesity to understand a metabolic subtype of osteoarthritis in rats. Osteoarthr Cartil 2015;23:957-65.
11. Schott EM, Farnsworth CW, Grier A, et al. Targeting the gut microbiome to treat the osteoarthritis of obesity. JCI Insight 2018;3:95997.
12. So JS, Song MK, Kwon HK, et al. Lactobacillus casei enhances type II collagen/glucosamine-mediated suppression of inflammatory responses in experimental osteoarthritis. Life Sci 2011;88:358-66.
13. Ulici V, Kelley KL, Azcarate-Peril MA, et al. Osteoarthritis induced by destabilization of the medial meniscus is reduced in germ-free mice. Osteoarthr Cartil 2018;26:1098-109.
14. Robosky LC, Wells DF, Egnash LA, Manning ML, Reily MD, Robertson DG. Metabonomic identification of two distinct phenotypes in Sprague-Dawley (Crl:CD(SD)) rats. Toxicol Sci 2005;87:277-84.
15. Wang Q, Huang SQ, Li CQ, Xu Q, Zeng QP. Akkermansia muciniphila may determine chondroitin sulfate ameliorating or aggravating osteoarthritis. Front Microbiol 2017;8:1955.
16. Sane F, Scuotto A, Pierrat V, Kacet N, Hober D, Romond MB. Diabetes progression and alterations in gut bacterial translocation: prevention by diet supplementation with human milk in NOD mice. J Nutr Biochem 2018;62:108-22.
17. Sousa Valente J. The pharmacology of pain associated with the monoiodoacetate model of osteoarthritis. Front Pharmacol 2019;10:974.
18. Cui Y, Zhang L, Wang X, et al. Roles of intestinal Parabacteroides in human health and diseases. FEMS Microbiol Lett 2022;369:fnac072.
19. Derrien M, Van Baarlen P, Hooiveld G, Norin E, Müller M, de Vos WM. Modulation of mucosal immune response, tolerance, and proliferation in mice colonized by the mucin-degrader akkermansia muciniphila. Front Microbiol 2011;2:166.
20. Awadel-Kariem FM, Patel P, Kapoor J, Brazier JS, Goldstein EJ. First report of Parabacteroides goldsteinii bacteraemia in a patient with complicated intra-abdominal infection. Anaerobe 2010;16:223-5.
21. Wang Z, Zhu H, Jiang Q, Zhu YZ. The gut microbiome as non-invasive biomarkers for identifying overweight people at risk for osteoarthritis. Microb Pathog 2021;157:104976.
22. Kempsell KE, Cox CJ, Hurle M, et al. Reverse transcriptase-PCR analysis of bacterial rRNA for detection and characterization of bacterial species in arthritis synovial tissue. Infect Immun 2000;68:6012-26.
23. Parvin -Roo S, Long MJ, Iennarella-Servantes CA, Jergens A, Wannemuehler MJ. Resident microbiota selectively modulates intestinal permeability in healthy adult C3H mice. Available from: https://www.gastrojournal.org/article/S0016-5085(20)32058-8/pdf?referrer=https%3A%2F%2Fwww.researchgate.net%2F. [Last accessed on 8 May 2023].
24. Sakamoto M, Benno Y. Reclassification of Bacteroides distasonis, Bacteroides goldsteinii and Bacteroides merdae as Parabacteroides distasonis gen. nov., comb. nov., Parabacteroides goldsteinii comb. nov. and Parabacteroides merdae comb. nov. Int J Syst Evol Microbiol 2006;56:1599-605.
25. Lukovac S, Belzer C, Pellis L, et al. Differential modulation by Akkermansia muciniphila and Faecalibacterium prausnitzii of host peripheral lipid metabolism and histone acetylation in mouse gut organoids. mBio 2014:5.
26. Park J, Kim M, Kang SG, et al. Short-chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR-S6K pathway. Mucosal Immunol 2015;8:80-93.
27. Zhao J, Liu M, Shi T, et al. Analysis of serum metabolomics in rats with osteoarthritis by mass spectrometry. Molecules 2021;26:7181.
28. Nieves KM, Hirota SA, Flannigan KL. Xenobiotic receptors and the regulation of intestinal homeostasis: harnessing the chemical output of the intestinal microbiota. Am J Physiol Gastrointest Liver Physiol 2022;322:G268-81.
29. Ye X, Li H, Anjum K, et al. Dual role of indoles derived from intestinal microbiota on human health. Front Immunol 2022;13:903526.
30. Modoux M, Rolhion N, Lefevre JH, et al. Butyrate acts through HDAC inhibition to enhance aryl hydrocarbon receptor activation by gut microbiota-derived ligands. Gut Microbes 2022;14:2105637.
31. Rosser EC, Piper CJM, Matei DE, et al. Microbiota-derived metabolites suppress arthritis by amplifying aryl-hydrocarbon receptor activation in regulatory b cells. Cell Metab 2020;31:837-851.e10.
32. Shen J, Yang L, You K, et al. Indole-3-acetic acid alters intestinal microbiota and alleviates ankylosing spondylitis in mice. Front Immunol 2022;13:762580.
